Dr. Karl Kuchler joins SOLVO Strategic Advisory Board
September 19, 2006
SOLVO Biotechnology announced today the appointment of Karl Kuchler to its Strategic Advisory Board. Dr. Kuchler is widely recognized in the drug transporter community as leader and champion of collaboration between academia and industry! "We are extremely pleased and deeply honored to have such a leading scientist as Karl Kuchler join our Strategic Advisory Board" said SOLVO's President and CEO Mr Ernő Duda. Karl Kuchler, PhD is the Associate Professor of Molecular Genetics at the Medical University Vienna, Max F. Perutz Laboratories, Department of Medical Biochemistry, Austria. He was trained as a biochemist at the Technical University of Graz where he also received his PhD. His research interests are focused on the following areas: Molecular structure-function analysis and expression regulation of ABC proteins in lower eukaryotes (yeast, fungal pathogens, stress response, drug resistance mechanisms and signal transduction); Molecular mechanism of fungal virulence and host-pathogen interaction (Signal transduction during host cell invasion, immune response, animal models to study pathogenesis); Molecular medicine and systems biology of novel genes encoding mammalian ABC proteins (Genetic analysis of hepatic, intestinal and brain ABC transporters). Dr Kuchler has over 75 peer-reviewed publications; he is the editor of a number of books and various journals and the author of 2 patents. "Dr. Kuchler brings tremendous experience and broad scientific prospective into our Strategic Advisory Board. We are very excited and look forward to working with him for the development and promotion of new drug transporter technologies that will help reduce the cost and time of drug development" commented Dr. Peter Krajcsi, Chief Scientific Officer of SOLVO Biotechnology.Next entry: SOLVO and XenoTech LLC Announce North American Distribution and Service Representation Agreement
Previous entry: SOLVO New Service portfolio
